These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 11544530

  • 1. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice.
    Krimpenfort P, Quon KC, Mooi WJ, Loonstra A, Berns A.
    Nature; 2001 Sep 06; 413(6851):83-6. PubMed ID: 11544530
    [Abstract] [Full Text] [Related]

  • 2. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis.
    Sharpless NE, Bardeesy N, Lee KH, Carrasco D, Castrillon DH, Aguirre AJ, Wu EA, Horner JW, DePinho RA.
    Nature; 2001 Sep 06; 413(6851):86-91. PubMed ID: 11544531
    [Abstract] [Full Text] [Related]

  • 3. p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a.
    Krimpenfort P, Ijpenberg A, Song JY, van der Valk M, Nawijn M, Zevenhoven J, Berns A.
    Nature; 2007 Aug 23; 448(7156):943-6. PubMed ID: 17713536
    [Abstract] [Full Text] [Related]

  • 4. Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo.
    Sharpless NE, Kannan K, Xu J, Bosenberg MW, Chin L.
    Oncogene; 2003 Aug 07; 22(32):5055-9. PubMed ID: 12902988
    [Abstract] [Full Text] [Related]

  • 5. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
    D'Amico M, Wu K, Di Vizio D, Reutens AT, Stahl M, Fu M, Albanese C, Russell RG, Muller WJ, White M, Negassa A, Lee HW, DePinho RA, Pestell RG.
    Cancer Res; 2003 Jun 15; 63(12):3395-402. PubMed ID: 12810676
    [Abstract] [Full Text] [Related]

  • 6. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
    Sharpless NE, Ramsey MR, Balasubramanian P, Castrillon DH, DePinho RA.
    Oncogene; 2004 Jan 15; 23(2):379-85. PubMed ID: 14724566
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus.
    Gilley J, Fried M.
    Oncogene; 2001 Nov 01; 20(50):7447-52. PubMed ID: 11704876
    [Abstract] [Full Text] [Related]

  • 16. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
    Peng CY, Chen TC, Hung SP, Chen MF, Yeh CT, Tsai SL, Chu CM, Liaw YF.
    Anticancer Res; 2002 Nov 01; 22(2B):1265-71. PubMed ID: 12168936
    [Abstract] [Full Text] [Related]

  • 17. Induction of nevi and skin tumors in Ink4a/Arf Xpa knockout mice by neonatal, intermittent, or chronic UVB exposures.
    van Schanke A, van Venrooij GM, Jongsma MJ, Banus HA, Mullenders LH, van Kranen HJ, de Gruijl FR.
    Cancer Res; 2006 Mar 01; 66(5):2608-15. PubMed ID: 16510579
    [Abstract] [Full Text] [Related]

  • 18. Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background.
    Ackermann J, Frutschi M, Kaloulis K, McKee T, Trumpp A, Beermann F.
    Cancer Res; 2005 May 15; 65(10):4005-11. PubMed ID: 15899789
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
    Edmunds SC, Kelsell DP, Hungerford JL, Cree IA.
    Invest Ophthalmol Vis Sci; 2002 Sep 15; 43(9):2845-51. PubMed ID: 12202501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.